SPARC

Sun Pharma Advanced Research Company Share PriceSun Pharma Advanced Research Company

₹162.9
-0.4 (-0.24%)
As on 23 March, 2023 | 00:52 BSE: 532872 NSE: SPARC

Sun Pharma Advanced Research Company Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Sun Pharma Advanced Research Company

Start SIP

Sun Pharma Advanced Research Company Share Price

  • Over 1 Month -14.62%
  • Over 3 Month -24.48%
  • Over 6 Month -27.03%
  • Over 1 Year -43.82%

Sun Pharma Advanced Research Company Key Statistics

P/E Ratio -25
PEG Ratio 2.1
Market Cap Cr 5,287
Price to Book Ratio 169.3
EPS -6.4
Dividend 0
Relative Strength Index 28.43
Money Flow Index 14.17
MACD Signal -6.47
Average True Range 6.97

Sun Pharma Advanced Research Company Investment Rating

  • Master Rating:
  • Sun Pharma Advd.Resh. has an operating revenue of Rs. 216.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -44% needs improvement, Pre-tax margin of -148% needs improvement, ROE of -651% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 21 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 153 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharma Advanced Research Company Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 131322825
Operating Expenses Qtr Cr 1159410792
Operating Profit Qtr Cr 16-63-78-67
Depreciation Qtr Cr 3333
Interest Qtr Cr 3322
Tax Qtr Cr 0000
Net Profit Qtr Cr 10-68-82-71

Sun Pharma Advanced Research Company Technicals

EMA & SMA

Current Price
₹162.9
-0.4 (-0.24%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 179.59
  • 50 Day
  • 192.05
  • 100 Day
  • 204.3
  • 200 Day
  • 217.61
  • 20 Day
  • 182.2
  • 50 Day
  • 192.96
  • 100 Day
  • 213.35
  • 200 Day
  • 216.44

Sun Pharma Advanced Research Company Resistance and Support

PIVOT
₹164.
Resistance
First Resistance 165.9
Second Resistance 168.5
Third Resistance 170.4
RSI 28.43
MFI 14.17
MACD Single Line -6.47
MACD -8.67
Support
First Resistance 161.4
Second Resistance 159.5
Third Resistance 156.9

Sun Pharma Advanced Research Company Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 292,653 13,342,050 45.59
Week 434,358 17,105,026 39.38
1 Month 491,293 15,515,043 31.58
6 Month 690,568 16,628,876 24.08

Sun Pharma Advanced Research Company Result Highlights

Sun Pharma Advanced Research Company Synopsis

NSE-Medical-Biomed/Biotech

Sun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 137.25 Cr. and Equity Capital is Rs. 27.19 Cr. for the Year ended 31/03/2022. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
Market Cap 5,286
Sales 216
Shares in Float 11.03
No of funds 81
Yield
Book Value 141.65
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.17
Beta 1.29

Sun Pharma Advanced Research Company

Owner NameJan-23Dec-22Sep-22Jun-22
Promoters 65.67%68.22%69.09%
Mutual Funds 0.21%0.25%0.24%
Foreign Portfolio Investors 3.54%3.48%2.38%
Financial Institutions/ Banks
Individual Investors 16.34%16%15.7%
Others 14.24%12.05%12.59%

Sun Pharma Advanced Research Company Management

Name Designation
Mr. Dilip S Shanghvi Chairman
Dr. T Rajamannar Non Executive Director
Dr. Robert J Spiegel Non Executive Director
Mr. Sudhir V Valia Non Executive Director
Ms. Bhavna Doshi Independent Director
Dr. Ferzaan Engineer Independent Director

Sun Pharma Advanced Research Company Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharma Advanced Research Company MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 3302
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 388
Motilal Oswal Nifty 500 Fund Regular Growth 372
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 313
SBI Nifty Smallcap 250 Index Fund Regular Growth 159

Sun Pharma Advanced Research Company FAQs

What is Share Price of Sun Pharma Advanced Research Company ?

Sun Pharma Advanced Research Company share price is ₹162 As on 23 March, 2023 | 00:38

What is the Market Cap of Sun Pharma Advanced Research Company ?

The Market Cap of Sun Pharma Advanced Research Company is ₹5286.5 Cr As on 23 March, 2023 | 00:38

What is the P/E ratio of Sun Pharma Advanced Research Company ?

The P/E ratio of Sun Pharma Advanced Research Company is -25 As on 23 March, 2023 | 00:38

What is the PB ratio of Sun Pharma Advanced Research Company ?

The PB ratio of Sun Pharma Advanced Research Company is 169.3 As on 23 March, 2023 | 00:38

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number